Cargando...
SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation
Immunocompromised patients, including HSCT recipients, may have a poor prognosis after contracting COVID-19 due to the absence of a pathogen-specific adaptive immune response. One of the possible options for severe COVID-19 treatment may be the transfusion of hyperimmune SARS-CoV-2 convalescent plas...
Guardado en:
| Publicado en: | Transfus Apher Sci |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7604030/ https://ncbi.nlm.nih.gov/pubmed/33153902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.transci.2020.102983 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|